newsfilter
← Latest News
GlobeNewswire·

Apexigen to Participate in the Brookline Capital Markets Newport Symposium

SAN CARLOS, Calif., July 11, 2022 (GLOBE NEWSWIRE) -- Apexigen, Inc. ("Apexigen"), a clinical-stage company focused on developing innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology, today announced that A